Highlights
- Ramsay Health Care (ASX:RHC) reported FY26 group Revenue of AUD 18.6 billion.
- Underlying group EBIT increased 11.8% on a constant-currency basis during FY26.
- The proposed Ramsay Santé separation faces a Shareholder vote in November 2026.
- Ramsay Funding Group expects EBIT growth and Margin improvement in FY27.
Ramsay Health Care Limited operates private hospitals and healthcare services across Australia and international markets, including its UK businesses and an interest in Ramsay Santé. On November 17, 2026, Ramsay Health Care shares (ASX:RHC) were priced at AUD 53.04, down 3.48% during the trading session. The company is preparing for a shareholder decision on its proposed separation of Ramsay Santé while pursuing operating improvements across its remaining hospitals.
Hospital Operations Across Different Markets
Ramsay provides hospital treatment covering surgical procedures, specialist care and other clinical services. Its Australian operations form a central part of the group, while its UK portfolio includes hospitals and the Elysium mental healthcare business. Ramsay Santé operates services in continental Europe. Funding and labour requirements vary by market.
For Ramsay (ASX:RHC), managing theatre capacity and the types of procedures undertaken is particularly relevant to the Australian business. Insurer funding and workforce availability influence margins. Management has been directing attention towards higher-acuity activity, better capacity utilisation and revenue indexation.
Proposed Ramsay Santé Demerger
In October 2026, Ramsay published a demerger booklet concerning its proposed distribution of its Ramsay Santé holding to shareholders. Meetings scheduled for November 24 will determine whether the proposal receives the necessary approvals. Subject to approval, the transaction is expected to be implemented in December 2026. Its proposed structure would leave Ramsay with a more concentrated operational focus on Australia and the UK.
The group has stated that, if the separation proceeds, Ramsay Santé would be classified as a discontinued operation in its FY27 reporting. This classification would alter how continuing and discontinued activities appear in the accounts. Until relevant approvals and implementation occur, the proposed transaction should not be treated as completed. Ramsay (ASX:RHC) has also scheduled an investor day for November 30.
FY26 Financial Results and Hospital Performance
Ramsay reported FY26 group revenue of approximately AUD 18.6 billion, representing 4.2% constant-currency growth. Underlying group EBIT rose 11.8%, while underlying net profit after tax increased 22.9% on the same basis. Statutory reported net profit after tax was AUD 329 million. Underlying and reported Earnings differ.
Within the funding group, Australian and UK segment revenue and other income reached AUD 9.423 billion. Its EBITDA was AUD 1.240 billion and underlying EBIT was AUD 831.4 million. Australia contributed AUD 629.9 million of EBIT and the UK AUD 176.9 million. The period included progress in Australian hospital utilisation and the ongoing operating programmes within the UK portfolio.
FY27 Outlook and Relevant Risks
Ramsay Funding Group expects EBIT growth and an improvement in EBIT margin in FY27, including contributions from Australia and both UK businesses. Funding Group Capital Expenditure guidance is AUD 480 million to AUD 520 million, while net financing expense including Lease costs is forecast at AUD 280 million to AUD 300 million. The outlook remains subject to operating conditions and stated assumptions.
Labour costs, insurer funding decisions, occupancy patterns and the pace of operating improvements remain relevant risks. In the UK, Elysium continues to contend with weak market Demand while implementing its turnaround programme. Approvals introduce additional uncertainty for Ramsay (ASX:RHC).
What to Watch Next
The November 24 shareholder meetings will provide the next formal decision point for the proposed separation. Subsequent disclosures may clarify the timetable, financial presentation and costs. Ramsay (ASX:RHC) is also expected to discuss operational priorities at its November investor day, with FY27 results later providing evidence of progress on hospital activity, cost management and margins.
Key Insights
Ramsay (ASX:RHC) enters FY27 following higher underlying FY26 earnings, with plans to simplify the group through a proposed Ramsay Santé separation. Australian hospital execution, UK operating recovery and transaction approvals are the principal near-term items to monitor. Reported results will need to be interpreted alongside any change to the consolidation perimeter.


_11_20_2026_20_27_34_097200.jpg)



Please wait processing your request...